Skip to main content
S&P 5007,811.54+0.59%DOW51,654.95+0.83%NASDAQ27,366.17+0.64%BTC$82,516.00+0.84%ETH$2,488.45+0.36%GOLD$4,220.30+1.52%OIL$91.66+0.19%
Smart Investors Daily
SID Premium
SG

OTC · SGIOY

Shionogi & Co., Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

$8.70

Down-$0.05 (-0.57%)

Updated Oct 11, 2026, 11:50 AM

SID Score

6.3/10

Composite research score

Smart Money

46/100

Neutral

Market cap
14.53B
P/E ratio
13.35
Dividend yield
2.31%
52-week range
— – —
Volume
20.58K
Avg. volume
100.96K

Price performance · SGIOY

SGIOY price history

1M range · 0 trading sessions · Daily adjusted prices

SGIOY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest SGIOY news

The latest Smart Investors Daily articles mentioning SGIOY.

Stock researchCompany · Overview

SGIOY research

Overview

Company profile and research snapshot.

Company profile

SHIONOGI & CO UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 9, 2026

Can Shionogi (TSE:4507) Support Its Price With Earnings After IntraBio?

Shionogi has delivered a solid share price gain over the past few years, helped recently by a high profile rare disease acquisition, which leaves a clear question for you as an investor: Is the current share price properly supported by the earnings the business is generating today and is expected to generate ahead? Over the past 3 years the stock has gained about 30.6%, which puts real pressure on the question of whether the current earnings justify that move. The planned US$2b purchase of...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By